Multibiomarker analysis in patients with acute myocardial infarction.

Christiana Schernthaner Michael LichtenauerBernhard WernlyVera PaarRudin PistulliIlonka RohmChristian JungHans-Reiner FigullaAttila YilmazJanne CadamuroElisabeth Haschke-BecherJohn PernowPaul Christian SchulzeUta C HoppeDaniel Kretzschmar

Published in: European journal of clinical investigation (2017)

Plasma levels of novel biomarkers were significantly elevated (sST2, GDF-15, H-FABP, suPAR) or inversely downregulated (fetuin A) in patients with AMI compared to a control group with excluded coronary artery disease. Significant correlations with various clinical parameters and standard biochemical markers were found.

Keyphrases

acute myocardial infarction
coronary artery disease
percutaneous coronary intervention
left ventricular
coronary artery bypass grafting
acute coronary syndrome
cardiovascular events
heart failure
cardiovascular disease